Skip to Content

Ascensia program increases access to CGM

Ascensia program increases access to CGM

BASEL, Switzerland – Ascensia Diabetes Care has launched a Patient Assistance Program to reduce out-of-pocket costs for its Eversense Continuous Glucose Monitoring System. “Our fundamental goal at Ascensia is to simplify and improve the lives of people living with diabetes through technologies that facilitate better outcomes and reduce the burden of managing the condition,” said Mary Puncochar, head of Ascensia’s Region US. “We therefore want to be able to offer Eversense to as many people as possible and we believe that over half of the people using insulin in the US could be eligible for our Patient Assistance Program.” Per the program, eligible patients pay the first $100 of their out-of-pocket costs, and Ascensia will then cover up to $300 of the remaining balance for each 90-day sensor. Overall, the program has the potential to save eligible Eversense users up to $1,200 per year. Ascensia last year partnered with Senseonics to distribute its implantable CGM systems, including the Eversense and Eversense XL.

Comments

To comment on this post, please log in to your account or set up an account now.